CIK 0001645460
- Non-accelerated filer
- Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473324577
- Phone
- +1 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $389,304
- in 3 filings
Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-14 | Gray Cameron Director | Option exercise | +61,111 | $2.70 | $165K | 738,611 |
| 2022-06-14 | Gray Cameron Director | Shares withheld for taxes | −51,562 | $3.20 | $165K | 687,049 |
| 2022-06-14 | Gray Cameron Director | Option exercise · Warrants | −61,111 | 0 | ||
| 2022-01-03 | Gray Cameron Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-01-04 | Gray Cameron Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-09-30 | Gray Cameron Director | Purchase | +5,000 | $15.30 | $77K | 677,500 |
| 2020-09-29 | Gray Cameron Director | Purchase | +5,000 | $15.00 | $75K | 672,500 |
| 2020-01-02 | Gray Cameron Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2019-01-02 | Gray Cameron Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2018-06-12 | Gray Cameron Director | Option exercise · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2017-12-29 | Gray Cameron Director | Other acquisition · Warrants | +192,495 | 192,495 |
Page 1 of 1 · 11 trades